TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion - Wikidata - awgldk - TriplyDB

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

http://www.wikidata.org/entity/Q57693484

about

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer Diagnosis of prostate cancer via nanotechnological approach Discovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate Tissue Emerging critical role of molecular testing in diagnostic genitourinary pathology Prostate cancer biomarkers: Are we hitting the mark?Role of the TMPRSS2-ERG gene fusion in prostate cancer TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography.Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease miRDeep*: an integrated application tool for miRNA identification from RNA sequencing data.ERG induces taxane resistance in castration-resistant prostate cancer Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation.New strategies in prostate cancer: translating genomics into the clinic Antibody-based detection of ERG rearrangement-positive prostate cancer Detection of TMPRSS2-ETS fusions by a multiprobe fluorescence in situ hybridization assay for the early diagnosis of prostate cancer: a pilot study ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells.Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis.ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.Evolving Personalized Therapy for Castration-Resistant Prostate Cancer.Oncogenic gene fusions in epithelial carcinomas Identification of the YES1 Kinase as a Therapeutic Target in Basal-Like Breast Cancers Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?ERG rearrangement is associated with prostate cancer-related death in Chinese prostate cancer patients Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells.A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.Mechanisms mediating androgen receptor reactivation after castration.The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features.Defining order and timing of mutations during cancer progression: the TO-DAG probabilistic graphical model Overexpression of Aquaporin-1 is a Prognostic Factor for Biochemical Recurrence in Prostate Adenocarcinoma.

P2860

Q24302687-1CBF3732-F3ED-4627-99B2-B7067B805EA2 Q24569630-FD2848DB-6928-4A2D-BE17-8542EC935BAD Q24606772-6DECA949-91FF-431D-A916-1C51B3EBFEE2 Q24629083-0695B229-BBF3-4EC0-99FD-F0D474FE0912 Q26752933-87D03BC6-46AF-470B-B32B-43F4CB989BEB Q26777322-BD18C407-00F8-4593-B41E-3203616CD6A3 Q26997884-F3FEAC48-9765-42D4-B764-4A806712B75C Q27021371-AADBE5C0-6CB7-4852-ABCE-807DC55532BC Q28071654-DAE814E1-CA2C-45D0-B063-26962A603B17 Q28269156-DFA223F8-BA6C-4345-9D1D-81E63645F302 Q28478908-86A632E3-F5A7-4145-8010-65BC12C127BF Q28546607-DB777235-6F53-4D75-B50D-699E237EF153 Q28771736-D8E851D5-F1F6-4204-836E-3B14E42C35AE Q30240027-66E54F11-8B1C-4C7E-9DAB-9338FE7714F3 Q30494070-9A6323DE-D1B3-4A7B-B544-234D0A57B161 Q30580665-FCD09D46-C8FD-4C6B-BC69-77DF402A30A0 Q30602046-3A432781-2239-452F-94DA-915641254457 Q33640983-522A41F3-37A1-4EFD-8B6B-F04B36480F58 Q33699391-53CCF4F5-2784-4746-BDA9-5FE459DE856E Q34007943-8E6D9AE2-CFB5-43E3-A39F-E20D93687AAA Q34009867-525D5E91-6F7C-4E9E-9769-60256B41A4F7 Q34084882-5E253D3D-286A-4E47-9B84-9091D6EF1217 Q34091302-C52CD64D-D397-4ECB-BF2D-EE27CAEF77F4 Q34108738-81CE9DC8-5605-4316-A24B-7F66552CF773 Q34302881-C08CB39F-5F6C-4256-867F-36DCB05BBC8D Q34411717-46AC2E50-BFA8-4837-AA1E-61D38550CAED Q34691562-9A4111D5-D684-4E91-9261-5C8409EFF5C6 Q34949690-F9321392-F53E-47D5-B374-000DE7BE2BA1 Q34972623-42F545FB-AED9-4E7B-A6F4-3DFD287CC18A Q35053261-B14DF408-41F0-489F-90D2-2B99DD2E6EE0 Q35091321-C4928231-1DEC-481B-B98B-BB85399AAF9F Q35199287-B0D668C9-B15A-47EC-A756-573F1D742A87 Q35248192-F4425DCD-4001-404D-BA1C-6F6CB03A845A Q35287094-D64DCC41-5D02-4611-A27A-5ACCADA2CC24 Q35535776-8E338808-F661-4033-B342-BB94044A9EBB Q35633454-7A2781D4-9624-4561-A6E0-6B4D496F4DAD Q35930506-B7864A25-7B4A-4628-82A3-BD09E2D2811B Q36147719-A84484EF-FC90-4C75-BBC3-82905E0A00CD Q36149716-F593BE59-066E-474E-9DE6-DBE9D50D2100 Q36183690-8A132919-F79F-42FC-8636-F87808E34BCC

P2860

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

http://www.wikidata.org/entity/Q57693484

description

im Juni 2007 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 June 2007

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2007

@uk

name

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

@en

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

@nl

type

label

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

@en

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

@nl

prefLabel

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

@en

TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

@nl

P1433

Q57693484-D8BC05EE-E69C-4735-92AE-764AD13235DB

P1476

Q57693484-0158D700-9227-4630-B214-4D609DE6798B

P2093

Q57693484-0EB96EC5-D927-48C1-AAC9-E7BC5A58DFB8

Q57693484-41636D7E-AE71-44A4-8CA1-DE0712420222

Q57693484-54CA4168-7805-40D4-87AF-AADE501192C2

Q57693484-857AB826-FB8D-405C-86B8-36BEAE8813EE

Q57693484-8B6BAB26-D894-4271-905D-0A5CBBCF7266

Q57693484-CEC63C58-F560-49A4-805B-F4DEDA6AEB14

Q57693484-DE28A09E-1961-440C-9234-8D6703E7E133

Q57693484-E6EFBD4C-851F-4071-939B-F1F277317348

Q57693484-ECE928C3-D1F9-4D44-B597-AD293BC16DBA

P304

Q57693484-33D42773-0421-4815-B775-9115518D01E9

P31

Q57693484-E5D21E98-6A9B-4C5B-84BE-A9571C8DFDBF

P356

Q57693484-5325DF1B-E8AE-41AE-939C-A3C7CC37F2A3

P407

Q57693484-C5F43804-8864-4B87-8F22-7644E203835F

P433

Q57693484-7F97D9E1-2584-45EB-B028-0F949663E446

P478

Q57693484-37315421-E3DE-43C7-B81A-0D647C4E3E81

P50

Q57693484-9F30954C-913E-4F07-BF8B-31FE6D6B211D

Q57693484-BEBAE017-12C4-49E2-A436-BC5A3CF012DC

P577

Q57693484-642D5292-6C01-48AB-825B-D171225D1D21

P698

Q57693484-9751F1AA-CD3C-4623-AF19-0AFA9BEF0A3F

P356

01.PAS.0000213424.38503.AA

P1433

The American Journal of Surgical Pathology

P1476

TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion

@en

P2093

Angelo M De Marzo

http://www.w3.org/2001/XMLSchema#string

Arul M Chinnaiyan

http://www.w3.org/2001/XMLSchema#string

Colin Collins

http://www.w3.org/2001/XMLSchema#string

Jeff Simko

http://www.w3.org/2001/XMLSchema#string

Juan-Miguel Mosquera

http://www.w3.org/2001/XMLSchema#string

Matthias D Hofer

http://www.w3.org/2001/XMLSchema#string

Pamela L Paris

http://www.w3.org/2001/XMLSchema#string

Sven Perner

http://www.w3.org/2001/XMLSchema#string

Tarek A Bismar

http://www.w3.org/2001/XMLSchema#string

P304

882-888

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.PAS.0000213424.38503.AA

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Demichelis

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17527075

http://www.w3.org/2001/XMLSchema#string